Literature DB >> 20562540

In vitro activity of the Qoustic Wound Therapy System against planktonic and biofilm bacteria.

Melissa J Karau1, Kerryl E Piper, James M Steckelberg, Steven J Kavros, Robin Patel.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether the Qoustic Wound Therapy System (Arobella Medical, LLC, Minnetonka, Minnesota) kills planktonic bacterial cells and/or removes bacterial biofilms.
DESIGN: The Qoustic Wound Therapy System was evaluated against Pseudomonas aeruginosa, Staphylococcus epidermidis, and Staphylococcus aureus planktonic cells and biofilms in vitro. MAIN
RESULTS: P aeruginosa, S epidermidis, and S aureus planktonic cells decreased by a mean of 5.10, 4.99, and 5.22 log10 colony-forming units/mL, respectively, with 4 Qoustic Wound Therapy System treatment minutes. After 10 minutes of treatment, P aeruginosa, S epidermidis, and S aureus biofilms decreased by a mean of 1.34, 1.46, and 1.02 log10 colony-forming units/cm, respectively.
CONCLUSION: The Qoustic Wound Therapy System, using the Qoustic Qurette, kills planktonic bacteria and reduces bacterial biofilms in vitro.

Entities:  

Mesh:

Year:  2010        PMID: 20562540     DOI: 10.1097/01.ASW.0000363557.45726.41

Source DB:  PubMed          Journal:  Adv Skin Wound Care        ISSN: 1527-7941            Impact factor:   2.347


  2 in total

1.  Rehabilitative interventions for ischaemic digital ulcers, pain, and hand functioning in systemic sclerosis: a prospective before-after study.

Authors:  Dalila Scaturro; Giuliana Guggino; Pietro Terrana; Fabio Vitagliani; Vincenzo Falco; Daniele Cuntrera; Maria Grazia Benedetti; Antimo Moretti; Giovanni Iolascon; Giulia Letizia Mauro
Journal:  BMC Musculoskelet Disord       Date:  2022-03-02       Impact factor: 2.362

2.  Ultra-rapid elimination of biofilms via the combustion of a nanoenergetic coating.

Authors:  Byung-Doo Lee; Rajagopalan Thiruvengadathan; Sachidevi Puttaswamy; Brandon M Smith; Keshab Gangopadhyay; Shubhra Gangopadhyay; Shramik Sengupta
Journal:  BMC Biotechnol       Date:  2013-03-27       Impact factor: 2.563

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.